DarioHealth NASDAQ: DRIO reported second-quarter 2026 revenue of $5.2 million, down from $5.6 million in the first quarter and $5.4 million a year earlier, as the company continued to shift away from pharmaceutical services revenue toward recurring B2B2C business.
DarioHealth Corp. (DRIO) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.76. This compares to a loss of $2.4 per share a year ago.
DarioHealth (DRIO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
Hui Fai Tam Caitong International Asset Management Co. Ltd. | 2 | $14.5 | $13.91 | -$0.59 | -4.07% |
Todd A. Rustman Clarity Capital Partners LLC | 1,412.5 | $43,222.5 | $10,268.87 | -$32,953.63 | -76.24% |
| Professional Services Industry | Industrials Sector | Erez Raphael CEO | NASDAQ (CM) Exchange | 23725P308 CUSIP |
| US Country | 163 Employees | - Last Dividend | 6 Oct 2014 Last Split | 6 Oct 2014 IPO Date |
DarioHealth Corp. is a forefront digital health company actively engaged in the development and distribution of a proprietary digital therapeutics platform and suite of solutions specifically designed to offer personalized and dynamic interventions. These interventions are powered by advanced data analytics and one-on-one coaching, targeting a variety of chronic conditions including diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. Initially founded as LabStyle Innovations Corp., the company underwent a rebranding to DarioHealth Corp. in July 2016. Headquartered in New York, New York, it extends its services across the United States, Canada, the European Union, Australia, and New Zealand, providing cutting-edge digital health solutions since its incorporation in 2011.
In addition to these innovative digital solutions, DarioHealth Corp. supplies native devices integral to the management and monitoring of chronic conditions. These include a glucose meter, blood pressure cuff, digital scale, and a biofeedback sensor device. Complementing its range of products, DarioHealth also provides live coaching services, offering personalized guidance and support to its users, thereby enhancing the effectiveness of its digital health solutions.